Law ❯ Securities Law

Federal Regulations

Investor Protection Corporate Governance Compliance Securities Exchange Act Disclosure Violations Corporate Law Crypto Trading CFTC Registration Statements Securities Exchange Act of 1934 Corporate Fraud Exchange Act Investment Company Act Tender Offer Rules International Law Litigation Process Disclosure Requirements Investor Rights FDA Litigation Cryptocurrency Filing Requirements Proxy Voting Anti-Fraud Provisions Tokenization False Statements Bribery Allegations

Investors Vie to Lead ImmunityBio Securities Suit

An FDA warning about misleading Anktiva promotions has turned investor losses into the central issue in the fight over who will control the case.

Regeneron Slides as Melanoma Combo Fails to Beat Keytruda in Phase 3

Medpace Investors Face June 8 Deadline to Seek Lead Role in Securities Suit Over Book-to-Bill Claims

Law Firms Urge PayPal Investors to Seek Lead Role in Securities Case Before April 20

ImmunityBio Faces Growing Securities Suits After FDA Flags Misleading Anktiva Claims

Soleno Therapeutics Sued in Federal Securities Class Action Over DCCR Safety and Launch Claims

SEC Staff Reaffirms Tokenized Securities Fall Under Existing U.S. Securities Laws

SEC Clarifies Tokenized Securities Rules, Flags Swap Risk for Synthetic Tokens

Sprouts Investors Face Jan. 26 Deadline to Seek Lead Role in Securities Class Action

Bitdeer Investors Urged to Consider Lead Role in Securities Case as Filing Deadline Approaches

Trump Order Directs Sweeping Reviews of Proxy Advisers ISS and Glass Lewis

Stride Faces Investor Probes After Enrollment Shortfall Disclosure

SEC Scales Back Operations in Shutdown, Freezing IPO Clearances and Routine Reviews

Charter Faces SDNY Securities Class Action Over ACP Fallout as Firms Seek Lead Plaintiffs